Pharmaceutical News

RSS

India's Supreme Court ruling on drug patent will promote affordable medicines, 'preserve' innovation incentives

Noting that India's Supreme Court on Monday ruled that drug maker Novartis "should not be given a patent for a cancer drug because it was too similar to Novartis's earlier version," a New York Times editorial writes, "The decision, which is the culmination of a high-profile, seven-year legal battle, should help protect the availability of cheap generic drugs for poor patients."

6 Apr 2013

China begins slaughter of birds in Shanghai market after 6th death from H7N9 announced; U.S., global experts begin vaccine research

"China announced a sixth death from a new bird flu strain Friday, while authorities in Shanghai halted the sale of live fowl and slaughtered all poultry at a market where the virus was detected in pigeons being sold for meat," the Associated Press reports (Wong, 4/5).

6 Apr 2013

Researchers map immune response to HIV, say findings could inform vaccine science

In research that could help in the search for an HIV vaccine, "American researchers have minutely tracked one person's powerful immune response to the virus to see how a series of mutations led to an antibody that can defeat many HIV strains," the New York Times reports (McNeil, 4/3).

5 Apr 2013

Anti-vaccination messages spread more easily than positive ones on Twitter, researchers find

On Twitter, a popular microblogging and social-networking service, statements about vaccines may have unexpected effects -- positive messages may backfire, according to a team of Penn State University researchers led by Marcel Salath-, an assistant professor of biology.

5 Apr 2013

UIC College of Pharmacy receives grant to train students in natural product drugs

Elizabeth Martinez hopes to one day discover a cure for menopausal symptoms using an herbal dietary supplement. With the help of a new federal training grant to the University of Illinois at Chicago College of Pharmacy, her vision may become reality.

5 Apr 2013

TSRI scientists identify new drugs for human prion disease

Human diseases caused by misfolded proteins known as prions are some of most rare yet terrifying on the planet—incurable with disturbing symptoms that include dementia, personality shifts, hallucinations and coordination problems.

4 Apr 2013

Dental anesthesia appears to affect the development of wisdom tooth

Researchers from Tufts University School of Dental Medicine have discovered a statistical association between the injection of local dental anesthesia given to children ages two to six and evidence of missing lower wisdom teeth.

4 Apr 2013

Finding solutions to protect U.S. troops against invisible killers

A Saint Louis University researcher has received a contract worth up to $980,000 to see if two cancer medications have the potential of protecting U.S. troops from biological agents that could be unleashed during an attack.

4 Apr 2013

Reuters examines implications of India's Novartis patent ruling for big pharma

Reuters examines the implications of India's Supreme Court ruling to reject drug maker Novartis's request for a new patent on an updated version of the cancer treatment Glivec on the pharmaceutical industry in India and across the developing world.

4 Apr 2013

Noven Pharmaceuticals files ANDA with FDA for approval of generic version of Exelon

Noven Pharmaceuticals, Inc. today confirmed that it has filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking approval to market its rivastigmine transdermal system in 4.6 mg/24 hours and 9.5 mg/24 hours dosage strengths.

4 Apr 2013

More must be done to find balance between drug innovation, affordable health care

"The decision by India's Supreme Court to overturn the patent on Novartis's cancer treatment Glivec is good news for more affordable health care and bad news for drug innovation," a Financial Times editorial states, adding, "It fails fundamentally to address either issue, both of which need wide-ranging reform.

4 Apr 2013

Tris Pharma gets FDA NDA approval for Karbinal ER Extended-release Oral Suspension

Tris Pharma, a specialty pharmaceutical company focused on developing innovative drug delivery technologies, today announced that the U.S. Food and Drug Administration has approved its New Drug Application for Karbinal ER (carbinoxamine maleate) Extended-release Oral Suspension 4mg/5ml, the first sustained-release histamine receptor blocking agent indicated for the treatment of seasonal and perennial allergic rhinitis in children ages 2 and up.

4 Apr 2013

FDA approves Mylan's ANDA for generic version of Zovirax Ointment

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Acyclovir Ointment USP, 5%.

4 Apr 2013

Study: V710 vaccine does not reduce postoperative Staphylococcus aureus infections

Use of a vaccine to prevent Staphylococcus aureus infections among patients undergoing cardiothoracic surgery did not reduce the rate of serious postoperative S aureus infections compared with placebo and was associated with increased mortality among patients who developed S aureus infections, according to a study in the April 3 issue of JAMA.

3 Apr 2013

Duloxetine drug alleviates pain from chemotherapy

Among patients with painful chemotherapy-induced peripheral neuropathy, use of the anti-depressant drug duloxetine for 5 weeks resulted in a greater reduction in pain compared with placebo, according to a study in the April 3 issue of JAMA.

3 Apr 2013

Research finds links between cannabis and mental illness

People with mental illnesses are more than seven times more likely to use cannabis weekly compared to people without a mental illness, according to researchers from the Centre for Addiction and Mental Health (CAMH) who studied U.S. data.

3 Apr 2013

Study suggests drugs prescribed to lower cholesterol may be effective against macular degeneration

A new study raises the intriguing possibility that drugs prescribed to lower cholesterol may be effective against macular degeneration, a blinding eye disease. Researchers at Washington University School of Medicine in St. Louis have found that age-related macular degeneration, the leading cause of vision loss in Americans over 50, shares a common link with atherosclerosis.

3 Apr 2013

BIND Therapeutics and Pfizer sign collaboration agreement to develop, commercialize Accurins

BIND Therapeutics, a clinical-stage biopharmaceutical company developing a new class of highly selective targeted and programmable therapeutics called Accurins, announced today that it has entered into a global collaboration agreement with Pfizer Inc. to develop and commercialize Accurins utilizing select small molecule targeted therapies.

3 Apr 2013

PARP inhibitors can be novel treatment strategy for cisplatin-resistant cancer

Poly (ADP-ribose) polymerase inhibitors may be a novel treatment strategy for patients with cancer that has become resistant to the commonly used chemotherapy drug cisplatin, according to data from a preclinical study published in Cancer Research, a journal of the American Association for Cancer Research.

3 Apr 2013

Media outlets examine reaction to India's Supreme Court ruling on Novartis patent case

"In a decisive victory for India's pharmaceutical industry, India's Supreme Court rejected Novartis' patent application for the cancer drug Glivec on Monday, ending a seven-year battle by the Swiss drug maker to get a patent in India on its powerful leukemia drug," Time reports (Mahr, 4/1).

3 Apr 2013

Pharmaceutical News

India's Supreme Court ruling on drug patent will promote affordable medicines, 'preserve' innovation incentives

China begins slaughter of birds in Shanghai market after 6th death from H7N9 announced; U.S., global experts begin vaccine research

Researchers map immune response to HIV, say findings could inform vaccine science

Anti-vaccination messages spread more easily than positive ones on Twitter, researchers find

UIC College of Pharmacy receives grant to train students in natural product drugs

TSRI scientists identify new drugs for human prion disease

Dental anesthesia appears to affect the development of wisdom tooth

Finding solutions to protect U.S. troops against invisible killers

Reuters examines implications of India's Novartis patent ruling for big pharma

Noven Pharmaceuticals files ANDA with FDA for approval of generic version of Exelon

More must be done to find balance between drug innovation, affordable health care

Tris Pharma gets FDA NDA approval for Karbinal ER Extended-release Oral Suspension

FDA approves Mylan's ANDA for generic version of Zovirax Ointment

Study: V710 vaccine does not reduce postoperative Staphylococcus aureus infections

Duloxetine drug alleviates pain from chemotherapy

Research finds links between cannabis and mental illness

Study suggests drugs prescribed to lower cholesterol may be effective against macular degeneration

BIND Therapeutics and Pfizer sign collaboration agreement to develop, commercialize Accurins

PARP inhibitors can be novel treatment strategy for cisplatin-resistant cancer

Media outlets examine reaction to India's Supreme Court ruling on Novartis patent case

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News